GoodRx (NasdaqGS:GDRX) Q4 2025 Earnings call February 26, 2026 08:00 AM ET Company ParticipantsAubrey Reynolds - Director of Investor RelationsCameron Harbilas - Equity Research AssociateChris McGinnis - CFOJohn Ransom - Managing DirectorLaura Jensen - Chief Commercial Officer and President of Pharma DirectLisa Gill - Managing DirectorSteven Valiquette - Managing DirectorWendy Barnes - CEOConference Call ParticipantsAllen Lutz - Senior Equity Research AnalystDaniel Grosslight - Senior Research AnalystGeorge ...

GoodRx (NasdaqGS:GDRX) Q4 2025 Earnings call February 26, 2026 08:00 AM ET Speaker9Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx fourth quarter and full year 2025 earnings call. As a reminder, today's conference is being recorded. I would like now to introduce your host for today's call, Aubrey Reynolds, Director of Investor Relations. Ms. Reynolds, you may begin.Speaker1Thank you, Operator. Good morning, everyone, and welcome to GoodRx's earnings conference call for the fourth ...